-
September 28, 2021 Lupin Launches Droxidopa Capsules in the United States
-
September 15, 2021 Lupin Launches Authorized Generic Version of Duexis® in the United States
-
September 6, 2021 TB Alliance and Lupin Announce Commercial Partnership for New Therapy for Highly Drug-Resistant TB
-
August 24, 2021 Lupin Launches Luforbec® for treatment of Asthma & COPD, in the UK
-
August 16, 2021 Lupin Receives Tentative U.S. FDA Approval for Brivaracetam Tablets
-
August 10, 2021 Lupin Quarter I FY2022 Results
-
July 30, 2021 Lupin Acquires Southern Cross Pharma in Australia
-
July 13, 2021 Lupin Launches Tavaborole Topical Solution in the United States
-
July 1, 2021 Lupin Announces FDA Approval of Supplemental New Drug Application for SOLOSEC® (secnidazole) for the Treatment of Trichomoniasis
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications